Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Solid Tumours × BGC945 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumours 1

Interventions

AZD 6244 5 GSK 1363089 3 pazopanib 1 ispinesib 1 Topotecan 1 SLC-0111 1 Rifampin 1 Omeprazole 1 Moxifloxacin 1 Midazolam 1 Itraconazole 1 Granisetron 1 Fluconazole 1 Famotidine 1 Cytochrome P-450 CYP3A 1 Cytochrome P-450 CYP2C19 1 Cytochrome P-450 CYP1A2 1 Carboplatin 1 Carbon-14 1 Caffeine 1 CH5183284 1 BGC945 1 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate 1 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02360345 2024-09-26

ONX-0801

Royal Marsden NHS Foundation Trust

Phase 1 Completed

Other solid neoplasm

Solid Tumours

Data powered by HemOnc (CC BY 4.0) Colophon ⚡